glp-1 drugs and cancer linked to lower rates of some cancers The science around GLP-1 drugs

The incubation of human atrial cardiomyocytes with canagliflozin reduced inflammation and apoptosis, suppressing myocardial NADPH oxidase activity, and improved nitric oxide synthase (NOS) coupling via SGLT1/AMPK/Rac1 signaling [112]

Am J Physiol Renal Physiol (2009) 297(6):F164755

Potential effects of GLP-1s on vision and eye health GLP-1 medications and vision: A closer look The weight loss drugs shrinking Americas waistlines might be affecting the countrys eyesight in both positive and negative ways

28 A crucial tool to lower costs is swift generic competition, and addressing the patent and exclusivity landscape for drug-device combinations such as GLP-1 receptor agonists is key for facilitating such competition

Aiming to be an innovative leader in the cardiovascular and metabolic (CVM) disease area, Innovent is committed to accelerating the delivery of this drug to benefit a broad population in China